Leveraging Xealth’s digital health platform and API, Stel brings secure monitoring device program live from underserved populations direct to their care teams, right in their EHR workflow
SEATTLE and PHILADELPHIA, May 07, 2024 (GLOBE NEWSWIRE) — Xealth, the leader in enabling digital health at scale, today announced that Stel Life, a leader in health monitoring device connectivity, has connected with Xealth’s digital health platform to bring vitals data from a patient’s device into the care team’s workflow faster and with added privacy, maintaining a no-protected health information (PHI) integration between Xealth and Stel.
Enrolling the patients is the first step in any remote patient monitoring (RPM) program, but the data needs to be easily accessible by researchers and care teams. Xealth’s integration into the EHR brings the Stel program into clinical workflows, ensuring that providers have instant access to important health data. Additionally, as an extra privacy measure, Stel’s integration with Xealth is implemented without health systems sharing PHI with Stel.
“We’re privileged to support innovative health systems in evolving care to the home and improving the overall health of the communities they serve,” said Sid Kandan, CEO of Stel Life. “We are excited to deploy Stel through the Xealth digital health platform, as not only does Xealth help power provider workflows, but also maintains our unidentified data design. We don’t need to know exactly who the patient is, but trust Xealth to get data to records.”
Stel Life seamlessly and securely connects wireless health devices to care teams using cellular networks that function even in areas with low broadband access. Stel Life’s ecosystem allows health systems to standardize their device connectivity across hundreds of devices, including scales, blood pressure cuffs, glucometers, continuous glucose monitors (CGMs), wearables, and more. This device data surfaces patient trends via Xealth’s digital health platform, enhances a hospital’s ability to monitor patients outside of the hospital, enabling tailored care plans, quicker interventions and better outcomes.
“We simplify digital access by improving access to care, both for patients and the providers responsible for their care,” said Mike McSherry, CEO of Xealth. “The Stel Hub works without patients needing smartphones or Wi-Fi, connecting care to track behavior and outcomes. We are excited to partner with Stel to make monitoring simpler and more secure.”
About Stel Life
Stel Life simplifies health connectivity for patients, care teams, digital health, and device companies.
Healthcare leaders are struggling with the reality of the digital divide and integrating hundreds of point solutions across the care continuum. With Stel, patients don’t require Wi-Fi, smartphones, or tech-literacy to connect with their care teams. Patients use wireless health devices near a Stel Hub. Stel passively and securely connects the device data to their care team’s Electronic Health Records (EHR) or preferred platform without risking Protected Health Information (PHI) or complicated workflows. Stel’s patented connectivity and services have allowed enterprise health systems to quickly and seamlessly launch and scale hundreds of virtual care programs without requiring PHI or burdening providers.
For more information, visit www.stel.life or follow us on LinkedIn or Twitter.
About Xealth
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity. Xealth spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include Advocate Aurora Enterprises, Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, Cerner, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network.
For more information, visit www.xealth.com or follow us on LinkedIn or Twitter.
CONTACT: Heather Caouette RAE Communications +1 508-579-3894 heatherc@rae-communications.com
- EGBN Investor News: If You Have Suffered Losses in Eagle Bancorp, Inc. (NASDAQ: EGBN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - June 15, 2025
- Backblaze Investor News: If You Have Suffered Losses in Backblaze, Inc. (NASDAQ: BLZE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - June 15, 2025
- Investigational combination of first-in-class bispecific antibodies TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease - June 15, 2025
